Karien M. Hamer

6.3k citations
22 papers · 3.7k indexed · 3 hit papers · h-index 19
Topics
Epigenetics and DNA Methylation (15 papers)Cancer-related gene regulation (15 papers)RNA modifications and cancer (8 papers)

In The Last Decade

Karien M. Hamer

22 papers receiving 3.6k citations

Hit Papers

In vitro expansion of single Lgr5+ liver stem cells induc...20132026201720212013201320232505007501000

Peers

Karien M. Hamer
Comparison fields: 5 of 110
  • Molecular Biology 2.4k
  • Oncology 828
  • Surgery 766
  • Hepatology 541
  • Genetics 484
Replace Monique M.A. Verstegen with:
Monique M.A. Verstegen Netherlands
Malgorzata Borowiak United States
S. Tamir Rashid United Kingdom
Joshua P. Frederick United States
Wim de Lau Netherlands
Alla Danilkovitch‐Miagkova United States
Mariko Shimokawa Japan
Ken-ichiro Kosai Japan
Shiro Yui Japan
Eugenio Montini Italy
Karien M. Hamer relative to Monique M.A. Verstegen Netherlands Monique M.A. Verstegen's profile →
Citations per field
00.5×4.1×
Monique M.A. Verstegen · 1×
Citations per year

Countries citing papers authored by Karien M. Hamer

Since Specialization
Citations

This map shows the geographic impact of Karien M. Hamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karien M. Hamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karien M. Hamer more than expected).

Fields of papers citing papers by Karien M. Hamer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karien M. Hamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karien M. Hamer. The network helps show where Karien M. Hamer may publish in the future.

Co-authorship network of co-authors of Karien M. Hamer

This figure shows the co-authorship network connecting the top 25 collaborators of Karien M. Hamer. A scholar is included among the top collaborators of Karien M. Hamer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karien M. Hamer. Karien M. Hamer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosisbreakdown →
125
2 219
3
Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axisbreakdown →
535
4
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regenerationbreakdown →
1149
5 13
6 5
7 109
8 6
9 74
10 62
11 41
12 221
13 82
14 138
15 196
16 164
17 103
18 142
19 48
20 65

About Karien M. Hamer

Karien M. Hamer is a scholar working on Molecular Biology, Biochemistry and Hepatology, having authored 22 papers that have together received 3.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), Cancer-related gene regulation (15 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Hepatology (541 citations), Molecular Biology (2.4k citations) and Oncology (828 citations). Karien M. Hamer has collaborated with scholars based in Netherlands, United States and Austria. Frequent co-authors include Arie P. Otte, David Satijn, Hans Clevers, Johan H. van Es, Robert G. Vries, Toshiro Sato, Meritxell Huch, Marc van de Wetering, Vivian Li and Sylvia F. Boj. Their work appears in journals such as Nature, Cell and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026